kynurenine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ward, JM | 1 |
| Stoyas, CA | 1 |
| Switonski, PM | 1 |
| Ichou, F | 1 |
| Fan, W | 1 |
| Collins, B | 1 |
| Wall, CE | 1 |
| Adanyeguh, I | 1 |
| Niu, C | 1 |
| Sopher, BL | 1 |
| Kinoshita, C | 1 |
| Morrison, RS | 1 |
| Durr, A | 1 |
| Muotri, AR | 1 |
| Evans, RM | 1 |
| Mochel, F | 1 |
| La Spada, AR | 1 |
1 other study available for kynurenine and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.
Topics: Adipose Tissue; Animals; Ataxin-7; Blood Glucose; Energy Metabolism; Humans; Kynurenine; Metabolomic | 2019 |